Actively Recruiting
Study of Optical Coherence Tomography Imaging in Coronary Artery Disease to Predict Long-Term Outcomes and Develop AI Tools
Led by Radboud University Medical Center · Updated on 2025-12-19
1000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to assess the value of optical coherence tomography OCT imaging for predicting outcomes in patients with coronary arterial disease. OCT provides detailed images of the coronary arteries and stented segments during regular cardiac catheterization. The study focuses on whether specific OCT features like plaque type, vulnerable areas, or stent optimization signs relate to long-term clinical events over a follow-up of up to 10 years. Participants undergo OCT imaging as part of their routine care, and their clinical data are collected for this prospective registry. The study also includes developing an artificial intelligence AI tool that uses anonymized OCT images to help automate and improve image interpretation. This AI development phase may last up to 5 years, running alongside the clinical outcome observation. Participants provide consent for their clinical data, OCT images, and follow-up information to be used for research. Follow-up includes collecting data on symptoms, medication use, hospital visits, cardiac procedures, and major heart events through medical records, questionnaires, and national registries. Data privacy is protected by coding and secure storage. The overall study duration may extend up to 10 years to gather comprehensive long-term outcome data.
CONDITIONS
Brief Title
Optical Coherence Tomography: Prognostic Value and Artificial Intelligence
Research Team
J
Joske L. van der Zande
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here